Record #17970

Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia

Citation lifecycle

How this paper is being cited

Pre-retraction
0
Same day
0
Post-retraction
212
% post-retraction
98.6%
~0.0 citations/yr before retraction · ~9.4 citations/yr after
citing papers

Who is still citing this work

Loading…